Initial neurological exam of multibacillary leprosy: Correlation between the presence of affected nerves and disability present at diagnosis and with the occurrence of overt neuritis;O exame neurológico inicial na hanseníase multibacilar: Correlação entre a presença de nervos afetados com incapacidades presentes no diagnóstico e com a ocorrência de neurites francas

Anais Brasileiros de Dermatologia

Volumn 78, Issue 5, 2003, Pages 561-568

  Fernandes Pimentel, Maria Inês ^a,d   Borges, Esther ^c   Nunes Sarno, Euzenir ^c   Da Costa Nery, José Augusto ^b   Rolo Gonçalves, Rosângela ^c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d NONE   (Brazil)

Author keywords

Leprosy; Neuritis; Peripheral nerves; Statistics on sequelae and disability

Indexed keywords

ARTICLE; CLINICAL EXAMINATION; DISABILITY; DISEASE PREDISPOSITION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTIBACILLARY LEPROSY; NEURITIS; PROGNOSIS;

EID: 0142166732     PISSN: 03650596     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0365-05962003000500005     Document Type: Article

References (23)

1. Ridley D S e Jopling W H. Classification of leprosy according to immunity. A five-group system. Int J Lepr 1966; 34(3): 255-272.
2. GUIA DE CONTROLE DA HANSENÍASE / Ministério da Saúde. Fundação Nacional de Saúde. Centro Nacional de Epidemiologia. Coordenação Nacional de Dermatologia Sanitária. 2a edição, Brasília, 1994, 156 p.
3. Rao P S, Subramanian M, Subramanian G. Deformity incidence in leprosy patients treated with multidrug therapy. Indian J Lepr 1994; 66 (4): 449-455.
4. Srinivasan H. Newer tasks for leprosy workers. Indian J Lepr 1990; 62 (4): 409-415.
5. Srinivasan H. Not by chemotherapy alone. Indian J Lepr 1994; 66 (2): 209-221.
6. Pearson J M H e Ross W F. Nerve involvement in leprosy pathology, differential diagnosis and principles of management. Lepr Rev 1975; 46: 199-212.
7. Job C K. Nerve damage in leprosy. Int J Lepr 1989; 57 (2): 532-539.
8. Pearson J M H. The evaluation of nerve damage in leprosy. Lepr Rev 1982; 53: 119-130.
9. HANSENIASE. ATIVIDADES DE CONTROLE E MANUAL DE PROCEDIMENTOS. Ministério da Saúde. Secretaria de Políticas de Saúde. Departamento de Atenção Básica. Área Técnica de Dermatologia Sanitária. Brasília, 2001, 178 p.
10. Schipper A, Lubbers W J, Hogeweg M e De Soldenhoff R. Disabilities of hands, feet and eyes in newly diagnosed leprosy patients in eastern Nepal. Lepr Rev 1994; 65 (3): 239-247.
11. Richardus J H, Finlay K M, Croft R P e Smith W C S. Nerve function impairment in leprosy at diagnosis and at completion of MDT: a retrospective cohort study of 786 patients in Bangladesh. Lepr Rev 1996; 67: 297-305.
12. Croft R P, Richardus J H, Nicholls P G e Smith W C. Nerve function impairment in leprosy: design, methodology, and intake status of a prospective cohort study of 2664 new leprosy cases in Bangladesh (The Bangladesh Acute Nerve Damage Study). Lepr Rev 1999; 70 (2): 140-159.
13. Shama P, Jar H K, Beena K R, Kaur H e Narayan R. Disabilities in multibacillary leprosy patients: before, during and after multidrug therapy. Indian J Lepr 1996; 68 (2): 127-136.
14. Saunderson P. The epidemiology of reactions and nerve damage. Lepr Rev 2000; 71 Suppl S106-S110.
15. Rose P e Waters M F R. Reversal reactions in leprosy and their management. Lepr Rev 1991; 62: 113-121.
16. Van Brakel W H, Khawas I B e Lucas S B. Reactions in leprosy: an epidemiological study of 386 patients in West Nepal. Lepr Rev 1994; 65 (3): 190-203.
17. Selvaraj G, Prabakar N, Muliyil J e Martin G. Incidence of disabilities among multibacillary cases after initiation of multidrug therapy and factors associated with the risk of developing disabilities. Indian J Lepr 1998; 70 Suppl 115-165.
18. De Rijk A J, Gabre S, Byass P e Berhanu T. Field evaluation of WHO-MDT of fixed duration, at ALERT, Ethiopia: the AMFES project. - II. Reaction and neuritis during and after MDT in PB and MB leprosy patients. Lepr Rev 1994; 65: 320-332.
19. Pimentel MIF. Neurites na hanseníase: significado de parâmetros clínicos e epidemiológicos na indução e agravamento das incapacidades fisicas em pacientes multibacilares. Tese. Universidade Federal do Rio de Janeiro, Rio de Janeiro, 1998.
20. Solomon S, Kurian N, Ramadas P e Rao P S. Incidence of nerve damage in leprosy patients treated with MDT. Int J Lepr 1998; 66 (4): 451-456.
21. Wittenhorst B, Vree M L, Ten Ham P B, e Velema J P. The National Leprosy Control Programme of Zimbabwe: a data analysis. 1983-1992. Lepr Ver 1998; 69 (1): 46-56.
22. Reddy B N e Bansal R D. An epidemiological study of leprosy disability in a leprosy endemic rural population of Pondicherry (South India). Indian J Lepr 1984; 56 (2): 191-199.
23. Sow S O, Tiendrebeogo A, Hamed Oould B, Lienhart C e Ponnighaus J M. Disabilities observed in new cases of leprosy diagnosed in the Bamako district (Mali) in 1994. Acta Leprol 1999; 11 (4): 161-170.